“As a conclusion, too often, the discussion on open access models is sometimes completely confused, sometimes too simplistic, and usually based on undue generalization of local situations and even singular experiences. It doesn’t reflect properly the variety of parameters that influence the way research is practiced and communicated amongst peers and towards societies at large. Therefore, we desperately need a better-informed discussion based on case studies and probably driven by the actor-network theory because it allows for a modelling of how diverse stakeholders interact in the scholarly communication process. Because we need not only open access, but above all open scholarly communication models that serve the actual needs of the research communities and societies to create knowledge and benefit from it, we need an open access model based on bibliodiversity.”
“The last decade has seen a worrying increase in the number of unethical research publications, as well as an exponential rise in so-called ‘predatory’ journals and publishers. High levels of trust are vital to ensuring that the publication and sharing of research results helps to advance research, the global pool of knowledge and the careers of researchers and investigators. Publication practices vary across both academic disciplines and countries, but there are common ethical standards and behaviours that ensure that articles that are published in trustworthy peer-reviewed journals are of the highest standards.”
“On this page you will find indicators on how the policies of journals and funding agencies favour open access, and the percentage of publications (green and gold) actually available through open access.
The indicators cover bibliometric data on publications, as well as data on funders’ and journals’ policies. Indicators and case studies will be updated over time.”
Creative Commons is pleased to announce an award of new funding in the amount of $800,000 over two years from Arcadia, a charitable fund of Lisbet Rausing and Peter Baldwin, in support of CC Search, a Creative Commons technology project designed to maximize discovery and use of openly licensed content in the Commons.
“Stephen Buranyi’s piece from last summer “Is the staggeringly profitable business of scientific publishing bad for science?” (short answer: yes) and Jon Tennant’s “Scholarly publishing is broken. Here’s how to fix it” are timely reminders that the open access movement matters to us as a society, that it is a movement that involves fighting against forces with priorities very different from our own, and that–in addition to reminders about what’s at stake in this battle–we need practical, actionable advice to get us where we want to go.”
“We believe more discourse around research is a good thing. To that end, we have partnered with Hypothesis, a third-party platform, to allow for annotation and discussion on our preprints services. Annotation on preprints will increase transparency in scientific practices by enabling researchers to collaborate, discuss research with peers, and share additional information directly on preprints both before and after they are posted.”
“As many smart people have predicted, consolidation within scholarly publishing will continue to make big news well into 2019. Clarivate acquires Kopernio. Elsevier acquires bepress, Plum Analytics, and SSRN. Wiley acquires Atypon, etc., etc. We have also discussed with great interest the desire of the big publishers to offer start-to-finish workflow solutions. Roger Schonfeld warned of “lock in” while others argued business diversification.”
The article itself says little about open access, open source software, or open infrastructure. But the comment section is almost entirely devoted to these topics.
“As I analyze the responses to the OCLC Research 2018 International Linked Data Survey for Implementers, I’m looking out for significant differences with the responses to the previous, 2015 survey. One change that jumped out at me was the surge of using Wikidata as a linked data source consumed by linked data projects or services.”
“OICR-funded drug discovery project’s unique ‘open science’ business model is accelerating the search for a solution to lethal pediatric brain cancers Diffuse intrinsic pontine glioma (DIPG) is a lethal and inoperable brain cancer with a median survival of less than a year from diagnosis. Finding solutions to this disease is challenging due to its rarity, scientific complexity and its presentation in pediatric populations. An OICR-funded team of researchers, led by Dr. Aled Edwards from M4K Pharma, have developed new potential drug candidates for DIPG that they will test in animal models in the coming months. They’ve reached this milestone ahead of schedule, with fewer resources required than anticipated, by using an ‘open drug discovery’ approach – sharing their methods and data with the greater research community to streamline the drug discovery process….”